TrialThe Lancet. Oncology2005

5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial.

Jane T Hickok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.